Drug class in one race
IL-36 receptor drugs for Psoriasis
3 tracked IL-36 receptor drugs in the Psoriasis race. The class explanation lives on the IL-36 receptor page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 41 Phase 2/31 Phase 2
Head-to-head evidence: HB0034 vs SHR-1139 · SHR-1139 vs spesolimab